+34 620 10 75 37info@nanbiosis.com

Singular

Singular

U13-S08. Atomic Force Microscopy indentation test

Atomic Force Microscopy indentation test

Atomic Force Microscopy can be used to measure the forces between the probe and the sample as a function of their mutual separation. This can be applied to perform force spectroscopy.

Customer benefits

Low forces on cells (nano-scale).

Target customer

Public and private research groups focused on mechanobiology

Additional information

Cantilever + cells
Force curve
Capsules
AFM Software
Read More

U10-S9.

Characterization and development of pulmonar formulations

Encapsulation of therapeutic actives of interest in formulations for pulmonary administration with possibility of lyophilisation to obtain a powder. The service has two cutting-edge equipments for the characterization of pulmonary formulations:
SprayTec laser diffraction system: allows the measurement of spray particle and spray droplet size distributions in real-time for more efficient product development of sprays and aerosols, with robust and reproducible droplet size data.
Next Generation Impactor: has been designed specifically for the pharmaceutical industry for testing metered-dose inhalers, drypowder inhalers, nebulizers and nasal sprays. It consists of a high performance cascade impactor for classifying aerosol particles into micrometer size fractions, providing relevant information about their distribution in the respiratory tract.

Customer benefits

The formulations can be characterized, following SOPs, in terms of particle size, polydisperstity index and zeta potential. Importantly, this service can also offer real-time droplet size distribution and aerosol particles classification analysis by means of SprayTec and Next Generation Impactor (NGI) technology.

Target customer

  • Preclinical use for the characterization of the pulmonary formulation prior to its implementation in in vivo models.
  • Companies interested in characterizing their formulations or their pulmonary administration systems.

References

Moreno-Sastre M, Pastor M, Esquisabel A, Sans E, Viñas M, Fleischer A, Palomino E, Bachiller D, Pedraz JL. Pulmonary delivery of tobramycin-loaded nanostructured lipid carriers for Pseudomonas aeruginosa infections associated with cystic fibrosis. Int J Pharm. 2016 Feb 10;498(1-2):263-73. doi: 10.1016/j.ijpharm.2015.12.028.

Additional information

U10 Pulmonar formulations characterization.tif

Read More

U10-S8.

3D bio-impression of scaffolding for regenerative medicine

The principle of 3D bioprinting consists of selecting the most suitable biomaterials and cell types to prepare a Bioink that should be able to promote cell growth and differentiation and present appropriate mechanical properties of the target tissue.
This service possess a wide variety of 3D bioprinting techniques avaliable, such as extrusion, droplet, electrospining, electrowritting and stereolithography.

Customer benefits

One of the main characteristics of this additive manufacturing technique is its ability to bioprint the desired layers, with specific cell orientation , and desired morphology of the bioprinted 3D scaffold in order to ressemble, as much as possible, the tissue of interest. To achieve this goal, rheology, texturometry, printability and biological assays are carried out.

On the one hand, this technology can be employed to develop 3D scaffolds specific for the regeneration of particular tissues. On the other hand, this strategy offers a 3D environment that mimics the tissue/ organ of interest in order to test potential therapeutic tools, which goes in accordance with the implementation of the 3R principle (replace, reduce and refine).

Target customer

  • Preclinical use for in vitro and in vivo models.
  • Pharmaceutical industry (e.g. cosmetics)

References

  • Lafuente-Merchan M, Ruiz-Alonso S, García-Villén F, Zabala A, de Retana AMO, Gallego I, Saenz-Del-Burgo L, Pedraz JL. 3D Bioprinted Hydroxyapatite or Graphene Oxide Containing Nanocellulose-Based Scaffolds for Bone Regeneration. Macromol Biosci. 2022 Nov;22(11):e2200236. doi: 10.1002/mabi.202200236.
  • Lafuente-Merchan M, Ruiz-Alonso S, Zabala A, Gálvez-Martín P, Marchal JA, Vázquez-Lasa B, Gallego I, Saenz-Del-Burgo L, Pedraz JL. Chondroitin and Dermatan Sulfate Bioinks for 3D Bioprinting and Cartilage Regeneration. Macromol Biosci. 2022 Mar;22(3):e2100435. doi: 10.1002/mabi.202100435.
  • Ruiz-Alonso S, Villate-Beitia I, Gallego I, Lafuente-Merchan M, Puras G, Saenz-Del-Burgo L, Pedraz JL. Current Insights Into 3D Bioprinting: An Advanced Approach for Eye Tissue Regeneration. Pharmaceutics. 2021 Feb 26;13(3):308. doi: 10.3390/pharmaceutics13030308.

Additional information

U10 Biorpinters.png 3D Bioprinters: BIO X 3D Bioprinter –CELLINK (left); R-GEN 100 –REGENHU (right).

https://www.nanbiosis.es/wp-content/uploads/2017/10/piel.jpg Bioprinted 3D scaffold

Read More

U8-S04. Graphene growth services (On-site&Remote) OUTSTANDING

Graphene growth services (On-site&Remote) OUTSTANDING

CVD graphene growth on copper foils and transfer of CVD graphene to rigid/flexible substrates.

Customer benefits

Adaptable platform for electrical characterization of microelectrodes to meet customer needs

Target customer

Research groups and SMEs

References

  • Masvidal-Codina E, Illa X et al., Nature Materials 18 (2019) 280-288
  • Bonaccini Calia et al., Nature Nanotechnology 17 (2022) 301-309
  • Brosel-Oliu et al. Small (2023) 2308857
Read More

U7-S11. Contact angle

Contact angle

The Contact angle service of U7 is specialized in the characterization of surface-liquid interactions at the macro-scale. One can measure contact angle of different liquids and determine the surface free energy of different surfaces under investigation, as well as the wettability properties of different surfaces or different coatings.

Customer benefits

Our Contact angle service benefits from being part of a bioengineering-specialized research centre, providing wide knowledge in the treatment of different surfaces to tailor their properties according to the final bio-application. We offer custom services, assuring close and direct interaction with the client, to meet conclusive results and high-quality needs.

Target customer

Our target customers are researchers in the field of bioengineering or R&D departments of biotech companies which want to test, characterize, or compare different substrates, materials or prototypes.

Additional information


Contact angle measurement of diiodomethane on silicon wafer.

Read More

U3-S04. Peptide libraries (Remote) OUTSTANDING

Peptide libraries.

Read More

U3-S03. Special amino acids for peptidomimetics synthesis (Remote) OUTSTANDING

Special amino acids for peptidomimetics synthesis (Remote) OUTSTANDING

– Synthesis of N-alkyl amino acids and other special amino acids
– Synthesis of peptoids (N-alkylglycine oligomers).
– Synthesis of β-peptide, γ- peptides, β,γ-peptides and α,β-peptides
– Synthesis of peptidomimetics
– Synthesis of hybrid-heterocycle- peptides

Customer benefits

  • Extensive experience in the synthesis of peptide oligomers from non-natural amino acids such as β-peptides, γ-peptides, β,γ-peptides and α,β-peptides.
  • Experience with peptides and peptide mimetics in solid phase and in solution.
  • Development of various strategies for large-scale production (hundreds of mg) of peptidomimetics.

Target customer

  • Research groups (drug delivery, molecular biology, pharmacology, nanotechnology, biotechnology)
  • Companies (biotech and pharma companies).

References

  • Hybrid cyclobutane/proline-containing peptidomimetics: the conformational constraint influences their cell-penetration ability. Illa, Ona ; Ospina, Jimena; Sanchez-Aparicio, Jose-Emilio; Pulido, Ximena ; Abengozar, Maria Angeles; Gaztelumendi, Nerea; Carbajo, Daniel; Nogues, Carme; Rivas, Luis ; Marechal, Jean-Didier; Royo, Miriam ; Ortuño, Rosa M. International Journal of Molecular Sciences (2021), 22, 5092.
  • Chiral cyclobutane-containing cell-penetrating peptides as selective vectors for anti-Leishmania drug delivery systems. Illa, Ona ; Olivares, Jose-Antonio; Gaztelumendi, Nerea; Martinez-Castro, Laura; Ospina, Jimena; Abengozar, Maria-Angeles; Sciortino, Giuseppe ; Marechal, Jean-Didier; Nogues, Carme; Royo, Miriam; Rivas, Luis; Ortuno, Rosa M. International Journal of Molecular Sciences (2020), 21, 7502.
  • A solid-phase combinatorial approach for indoloquinolizidine-peptides with high affinity at D1 and D2 dopamine receptors. Molero, Anabel; Vendrell, Marc; Bonaventura, Jordi; Zachmann, Julian; Lopez, Laura; Pardo, Leonardo; Lluis, Carme; Cortes, Antoni; Albericio, Fernando; Casado, Vicent; Royo, Miriam. European Journal of Medicinal Chemistry (2015), 97, 173-180.
  • Efficient γ-amino-proline-derived cell penetrating peptide-superparamagnetic iron oxide nanoparticle conjugates via aniline-catalyzed oxime chemistry as bimodal imaging nanoagents. Cavalli, Silvia; Carbajo, Daniel; Acosta, Milena; Lope-Piedrafita, Silvia; Candiota, Ana Paula; Arus, Carles; Royo, Miriam; Albericio, Fernando. Chemical Communications (2012), 48, 5322-5324.

Read More

U2-S08. Inmunochemical methods development

Inmunochemical methods development

The service offers custom tailored immunoassay development. It involves designing and optimizing assays for detecting specific analytes (such as proteins, antibodies, or other biomolecules) in biological samples. The service includes identifying necessary reagents, establishing assay parameters, and validating the assay’s performance.

Customer benefits

  • Tailored Solutions: By utilizing our custom tailored immunoassay development service, customers gain access to highly specialized expertise and resources, resulting in the creation of assays optimized for their unique requirements.
  • Enhanced Sensitivity: The service ensures optimal sensitivity, allowing for the detection of analytes at low concentrations.
  • Time and Cost Savings: Outsourcing immunoassay development to experts saves time and resources compared to in-house development.
  • Quality Assurance: Rigorous validation ensures reliable results, enhancing confidence in research outcomes.

Target customer

  • Research Institutions: Universities, research centers, and laboratories engaged in biomedical research.
  • Biotech Companies: Organizations involved in drug discovery, diagnostics, and therapeutic development.
  • Pharmaceutical Companies: Those working on antibody-based therapies or vaccines.
  • Healthcare Providers: Hospitals and clinics conducting specialized research.
  • Food & Environmental Quality Control Companies: Entities involved in:
    • Food Contaminant Detection: Developing antibody-based
      tests for identifying foodborne pathogens and toxins.
    • Environmental Contaminant Detection: Creating antibody-based assays for detecting environmental pollutants in air, water, and soil.

Additional information

Selected references:

  • G. Colom, A. Hernández-Albors, J. Barallat, A. Galan, A. Bayes-Genis, J.-P. Salvador, M.-P. Marco. A multiplexed immunochemical microarray for the determination of cardiovascular disease biomarkers. Microchim. Acta, 191, 54, 2023.
  • C. Adrover-Jaume, A. Clemente, B. Rodríguez-Urretavizcaya, L. Vilaplana, M.-Pilar Marco, E. Rojo-Molinero, A. Oliver, R. de la Rica. A paper biosensor for overcoming matrix effects interfering with the detection of sputum pyocyanin with competitive immunoassays. Microchim acta, 190, 441, 2023.
  • E. Montagut, J. Raya, M.-T. Martín Gómez, L. Vilaplana, B. Rodríguez- Urretavizcaya, M.-P. Marco. An Immunochemical Approach to detect the Quorum Sensing-Regulated Virulence Factor 2-Heptyl-4- Quinoline N-Oxide (HQNO) produced by Pseudomonas aeruginosa Clinical Isolates. Microbiol. Spect., 10(4), 1-12, 2022.
  • E. Montagut, G. Acosta, F. Albericio, M. Royo, G. Godoy-Tena, A. Lacoma, C. Prat, J.-P. Salvador, M.-P. Marco. Direct Quantitative Immunochemical Analysis of the Autoinducer Peptide IV (AIP-IV) for Diagnosing and Stratifying Staphylococcus aureus infections. ACS Infect. Dis., 8(3), 645-656, 2022.
  • B. Rodriguez-Urretavizcaya, N. Pascual, C. Pastells, M. T. Martin-Gomez, Ll. Vilaplana, M.-P. Marco. Diagnostic and Stratification of Pseudomonas aeruginosa Infected Patients by Immunochemical Quantitative Determination of Pyocyanin from Clinical Bacterial Isolates. Frontiers in Cell. Infect. Microbiol., 11, 786929, 2021. DOI: 10.3389/fcimb.2021.786929
Read More

U2-S07. Antibody purification

Antibody purification

Antibody purification involves the selective enrichment or specific isolation of antibodies from various sources, such as serum (for polyclonal antibodies), or cell culture supernatant (for monoclonal antibodies).

The main methods used for antibody purification are:

  • Physicochemical Fractionation: This method includes differential precipitation, size-exclusion, or ion exchange chromatography, based on size, charge, or other shared chemical characteristics It separates proteins that includes the immunoglobulins (antibodies) based on size, charge, or other shared chemical characteristics
  • Class-Specific Affinity: In this approach, specific antibody classes (e.g., IgG) are bound to solid phases using immobilized biological ligands (such as proteins A or G). This method purifies all antibodies of the target class without considering antigen specificity.
  • Antigen-Specific Affinity: Here, only antibodies in a sample that bind to a particular antigen are purified. Affinity chromatography is performed using a column packed with immobilized antigen (the same antigen used for immunization). Only antibodies that bind to the antigen are isolated. This method provides a higher yield of antigen-specific antibodies than Protein A/G affinity chromatography, though the total amount of recovered antibodies is lower.

Customer benefits

  • High Purity: Antibody purification ensures that the isolated antibodies are of high purity, minimizing contamination by other proteins.
  • Specificity: By using antigen-specific affinity purification, researchers obtain antibodies that specifically recognize their target antigen.
  • Consistent Results: Purified antibodies lead to more consistent and reliable experimental results.
  • Diagnostic and Therapeutic Applications: Purified antibodies are essential for diagnostic assays, therapeutic development, and research applications.
  • Quality: We operate under ISO 9001 quality standards, ensuring consistent, reliable antibody production.

Target customer

  • Research Institutions: Universities, research centers, and laboratories engaged in biomedical research.
  • Biotech Companies: Organizations involved in drug discovery, diagnostics, and therapeutic development.
  • Pharmaceutical Companies: Those working on antibody-based therapies or vaccines.
  • Healthcare Providers: Hospitals and clinics conducting specialized research.
  • Food & Environmental Quality Control Companies: Entities involved in:
    • Food Contaminant Detection: Developing antibody-based tests for identifying foodborne pathogens and toxins.
    • Environmental Contaminant Detection: Creating antibody-based assays for detecting environmental pollutants in air, water, and soil.

Additional information

Selected references:

  • Giovanna Roncador; Pablo Engel; Lorena Maestre; et al; Alison H.Banham., Nuria Pascual 2016. The European antibody network’s practical guide to finding and validating suitable antibodies for research. mAbs. Taylor & Francis Online. 8-1, pp.27-36.
  • B. Rodriguez-Urretavizcaya, N. Pascual, C. Pastells, M. T. Martin-Gomez, Ll. Vilaplana, M.-P. Marco. Diagnostic and Stratification of Pseudomonas aeruginosa Infected Patients by Immunochemical Quantitative Determination of Pyocyanin from Clinical Bacterial Isolates. Frontiers in Cell. Infect. Microbiol., 11, 786929, 2021. DOI: 10.3389/fcimb.2021.786929
Read More

U2-S06. In vitro antibody production

In vitro antibody production

We perform the production of monoclonal antibodies in vitro.
Hybridoma cells are first expanded in culture flask or high density culture devices (for larger amounts of antibody) to get the optimal cell density needed for the production.
The classical medium of production includes fetal calf serum (ultralow IgG, FCS) but our expertise allows us to provide a completely customized service according to your needs, without using FCS.
Supernatant containing the monoclonal antibodies is then periodically collected until the expected quantity of antibodies is obtained.

Depending on the nature of the sample, the expected antibody concentrations are for :­

  • Culture in flask: from 5 to 20 µg antibody/mL supernatant
  • ­ Culture in high density device : up to 1 mg antibody/mL supernatant

Customer benefits

  • Customization: The service can be tailored to meet the specific needs of each customer, allowing for personalized antibody production without using fetal calf serum (FCS).
  • Scalability: The service can accommodate both flask cultures and high-density devices, providing flexibility for different antibody quantities.
  • ISO 9001 Certification: We operate under ISO 9001:2015 quality standards, ensuring consistent and reliable antibody production.

Target customer

  • Research Institutions: Universities, research centers, and laboratories engaged in biomedical research.
  • Biotech Companies: Organizations involved in drug discovery, diagnostics, and therapeutic development.
  • Pharmaceutical Companies: Those working on antibody-based therapies or vaccines.
  • Healthcare Providers: Hospitals and clinics conducting specialized research.
  • Food & Environmental Quality Control Companies: Entities involved in:
    • Food Contaminant Detection: Developing antibody-based tests for identifying foodborne pathogens and toxins.
    • Environmental Contaminant Detection: Creating antibody-based assays for detecting environmental pollutants in air, water, and soil.

Additional information

Selected references:

  • Giovanna Roncador; Pablo Engel; Lorena Maestre; et al; Alison H.Banham., Nuria Pascual 2016. The European antibody network’s practical guide to finding and validating suitable antibodies for research. mAbs. Taylor & Francis Online. 8-1, pp.27-36
  • Rodriguez-Urretavizcaya, N. Pascual, C. Pastells, M. T. Martin-Gomez, Ll. Vilaplana, M.-P. Marco. Diagnostic and Stratification of Pseudomonas aeruginosa Infected Patients by Immunochemical Quantitative Determination of Pyocyanin from Clinical Bacterial Isolates. Frontiers in Cell. Infect. Microbiol., 11, 786929, 2021. DOI: 10.3389/fcimb.2021.786929

Read More